· Periodic Report
Q3 revenue KRW 2.4 billion, operating loss KRW 4.2 billion
Mezion sold KRW 2.4 billion in Q3 and lost KRW 4.2 billion from its main business; sales rose 13.7% from a year earlier and 9.9% from the previous quarter.
140410 · KOSDAQ · Based on DART filings
3 total · 20 per page
· Periodic Report
Mezion sold KRW 2.4 billion in Q3 and lost KRW 4.2 billion from its main business; sales rose 13.7% from a year earlier and 9.9% from the previous quarter.
· Report on Large Shareholdings
Kayne Holdings L.P. ended ties with 3 related parties and terminated a major contract, so its reported stake in Mezzion Pharma Co., Ltd. changed from 25.90% to 6.52%. It said no shares were actually disposed of.
· Report on Large Shareholdings
The stake of Park Dong Hyun and 6 related parties in Mezzion Pharma Co., Ltd. fell from 27.06% to 18.59% after Kayne Holdings L.P and Glamour Box Limited left the group.
Get app alerts for new disclosures from Mezzion Pharma Co., Ltd..